TruaceTracing the truth around AISaturday, September 5, 2026
TRV-2026-0984Version 1 · Certified

Written 2026-09-05 06:05:34 UTC · current record

Reason for this version

Certified into the record

Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-0984
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-09-05T06:05:34.543765Z
status: published
lens: p_space
sector: health
headline: Artificial intelligence-driven decision-making after endoscopic resection for early gastric cancer
dek: Early gastric cancer (EGC) is increasingly managed by endoscopic resection (ER); however, lymph node metastasis (LNM), which occurs in approximately 5%-10% of cases, remains the key determinant for recommending additional gastrectomy. Current guideline-based strategies, including the eCura system, provide structured risk stratification but rely on categorical decision-making and may lead to overtreatment, as nearly 90% of patients undergoing additional surgery do not have LNM. Artificial intelligence (AI) has em…
gain_title: (none)
problem_title: Artificial intelligence-driven decision-making after endoscopic resection for early gastric cancer: Current guideline-based strategies, including the eCura system, provide structured risk stratification but rely on categorical decision-making and may lead to overtreatment, as nearly 90% of patients undergoing additional surgery do not have LNM.
trace_subject: (none)
gain_reading: (none)
gain_evidence: (none)
problem_reading: Artificial intelligence-driven decision-making after endoscopic resection for early gastric cancer: Current guideline-based strategies, including the eCura system, provide structured risk stratification but rely on categorical decision-making and may lead to overtreatment, as nearly 90% of patients undergoing additional surgery do not have LNM.
problem_evidence: (none)
quick_read: Early gastric cancer (EGC) is increasingly managed by endoscopic resection (ER); however, lymph node metastasis (LNM), which occurs in approximately 5%-10% of cases, remains the key determinant for recommending additional gastrectomy. Current guideline-based strategies, including the eCura system, provide structured risk stratification but rely on categorical decision-making and may lead to overtreatment, as nearly 90% of patients undergoing additional surgery do not have LNM.

Artificial intelligence (AI) has emerged as a promising tool for improving LNM predictions. Machine learning models using clinicopathological variables have demonstrated promising discriminatory performance (area under the curve, 0.69-0.94), often outperforming conventional scoring systems such as eCura.
limitation: 
tag: Evidence-backed problem
key_points: Early gastric cancer (EGC) is increasingly managed by endoscopic resection (ER); however, lymph node metastasis (LNM), which occurs in approximately 5%-10% of cases, remains the key determinant for recommending additional gastrectomy. | Current guideline-based strategies, including the eCura system, provide structured risk stratification but rely on categorical decision-making and may lead to overtreatment, as nearly 90% of patients undergoing additional surgery do not have LNM. | Machine learning models using clinicopathological variables have demonstrated promising discriminatory performance (area under the curve, 0.69-0.94), often outperforming conventional scoring systems such as eCura.
rundown: Early gastric cancer (EGC) is increasingly managed by endoscopic resection (ER); however, lymph node metastasis (LNM), which occurs in approximately 5%-10% of cases, remains the key determinant for recommending additional gastrectomy. Current guideline-based strategies, including the eCura system, provide structured risk stratification but rely on categorical decision-making and may lead to overtreatment, as nearly 90% of patients undergoing additional surgery do not have LNM.

Artificial intelligence (AI) has emerged as a promising tool for improving LNM predictions. Machine learning models using clinicopathological variables have demonstrated promising discriminatory performance (area under the curve, 0.69-0.94), often outperforming conventional scoring systems such as eCura.
sources:
- peer_reviewed | Clinical Endoscopy | https://doi.org/10.5946/ce.2026.176 | 2026-09-04
prev: 0000000000000000000000000000000000000000000000000000000000000000
sha256
f2bcfa22e64e84e8ad7f4d8db86de6ce533334fc900f1dc3c66db2857ca7cc87
previous
0000000000000000000000000000000000000000000000000000000000000000
Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-0984 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.